Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Adult Patients With Sepsis
NCT07074990Completed
- Sponsor
- Tanta University
- Start
- Nov 2023
- Primary completion
- Aug 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of colchicine in sepsis (2 arms), sponsored by Tanta University. Primary endpoints: Serum Tumor necrosis factor-alpha at 10 months and Serum Malondialdehyde at 10 months. Started Nov 2023; status: completed.
02
Drugs
colchicine
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT07074990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07074990.